MIVACRON 20 mg/10 ml, solution for injection (IV) 5 ampoules of 10 ml
Active ingredients: Mivacurium, Mivacurium chloride
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Solution for injection5 ampoules of 10 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- MIVACRON 20 mg/10 ml, solution injectable (IV)
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 5 ampoule(s) en verre de 10 ml
- Marketing authorisation holder
- ASPEN PHARMA TRADING (IRLANDE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 9 Dec 2010
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65201385CIP75772351CIP133400957723514Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MIVACURIUMsolution | 20,00 mg · une ampoule | FT |
| MIVACURIUM (CHLORURE DE)solution | 21,40 mg · une ampoule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.